Stella Diagnostics (Stella Diagnostics) Debt-to-Equity : -0.09 (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics Debt-to-Equity?

Stella Diagnostics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.65 Mil. Stella Diagnostics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.80 Mil. Stella Diagnostics's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $-16.42 Mil. Stella Diagnostics's debt to equity for the quarter that ended in Sep. 2023 was -0.09.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Stella Diagnostics's Debt-to-Equity or its related term are showing as below:

SLDX' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.09 Med: -0.09 Max: -0.09
Current: -0.09

During the past 0 years, the highest Debt-to-Equity Ratio of Stella Diagnostics was -0.09. The lowest was -0.09. And the median was -0.09.

SLDX's Debt-to-Equity is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 0.22 vs SLDX: -0.09

Stella Diagnostics Debt-to-Equity Historical Data

The historical data trend for Stella Diagnostics's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics Debt-to-Equity Chart

Stella Diagnostics Annual Data

Trend

Debt-to-Equity

Stella Diagnostics Quarterly Data
	Sep22	Sep23
Debt-to-Equity	N/A	-0.09

Competitive Comparison of Stella Diagnostics's Debt-to-Equity

For the Diagnostics & Research subindustry, Stella Diagnostics's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stella Diagnostics's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Stella Diagnostics's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Stella Diagnostics's Debt-to-Equity falls into.

Stella Diagnostics Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Stella Diagnostics's Debt to Equity Ratio for the fiscal year that ended in . 20 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(	+	)	/	N/A
	=	N/A

Stella Diagnostics's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.648	+	0.798)	/	-16.422
	=	-0.09

Stella Diagnostics (OTCPK:SLDX) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Stella Diagnostics Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Stella Diagnostics (Stella Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104

Website

https://www.stelladx.com

Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.